4Standl E, Schnell O. Endothelial function in health and disease: new insights into the gensis of cardiovascular disease [J]. Am J Med,2000. 105 : 325 - 395.
3GalatiusSS,WroblewskiH,VibekeBS,etal.Endothelin and Von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy:different stimuli for release before and after heart transplantationJ.AmHeart[J],1999,137:549-554
4Lip G Y H,BlannA.Von Willebrand factor:a marker of endothelial dysfunction in vascular disorders[J].CardiovascRes,1997,34:255-265
5Bautista L E, Vera LM, Arenas IA, et al. Independent association between inflammatory markers (reactive protein , interleukin26 , and TNF2alpha) and essential hypertension[ J ]. J Hum Hypertens ,2005,19 (2) : 149-157
6Cymerys M, Chyrek R, Bogdanski P, et al. Evaluation of acute phase proteins in hypertensive and obese patients [ J ]. Pol Merkuriusz Lek ,2003,15 (88) :352-355
7Vanhoutle PM. Endothelium and control of vascular function [ J ]. Hypertension , 1989,13 ( 6 Pt 2) :658 - 667
8Recasens M, Ricart W, Femandez2Real JM. Obesity and inflammation[J]. Rev Med Univ Navarra,2004,48 ( 2 ) :49 - 54
9Badr K,Wainwright CL. Inflammation in the cardiovascular system:here , there and everywhere [ J ]. Curr Opin Pharma2col,2004,4 : 107 - 1091
